Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

NNASDAQ:ELVN
47.62
USD
-1.18
(-2.42%)
-1.69EPS
3.37BMarket Cap
Mar 18Next Earn

Enliven Therapeutics, Inc. Documents

Q3 FY2026 · Earnings release

Read Enliven Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this earnings release
Create a free account to start reading

Full documents are included with Professional

Q3 FY2026 documents